A virtual crossmatch protocol significantly increases access of highly sensitized patients to deceased donor kidney transplantation

Transplantation

Volumn 86, Issue 12, 2008, Pages 1864-1868

  Bingaman, Adam W ^a   Murphey, Cathi L ^b   Palma Vargas, Juan ^a   Wright, Francis ^a  

^a TEXAS TRANSPLANT INSTITUTE   (United States)

^b Southwest Immunodiagnostics Laboratory   (United States)

Author keywords

Allocation; Crossmatch; Kidney

Indexed keywords

ALEMTUZUMAB; DIPHENHYDRAMINE; HLA ANTIBODY; IMMUNOGLOBULIN; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PARACETAMOL; TACROLIMUS; THYMOCYTE ANTIBODY; ALLOANTIBODY; HLA ANTIGEN; HLA ANTIGEN CLASS 1; HLA D ANTIGEN;

ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; COST CONTROL; GRAFT RECIPIENT; HISTOCOMPATIBILITY; HLA SYSTEM; HOSPITAL ADMISSION; HUMAN; KIDNEY DONOR; KIDNEY GRAFT; KIDNEY GRAFT REJECTION; KIDNEY TRANSPLANTATION; MEDICAL RECORD REVIEW; PLASMAPHERESIS; PREDICTION; PRIORITY JOURNAL; SINGLE DRUG DOSE; SOLID; ALLOTRANSPLANTATION; CADAVER; COMPUTER INTERFACE; DONOR; GRAFT SURVIVAL; HISTOCOMPATIBILITY TEST; IMMUNIZATION; IMMUNOLOGY; METHODOLOGY; RETROSPECTIVE STUDY; TRANSPLANTATION TOLERANCE;

CADAVER; GRAFT SURVIVAL; HISTOCOMPATIBILITY ANTIGENS CLASS I; HISTOCOMPATIBILITY TESTING; HLA ANTIGENS; HLA-D ANTIGENS; IMMUNIZATION; ISOANTIBODIES; KIDNEY TRANSPLANTATION; RETROSPECTIVE STUDIES; TISSUE DONORS; TRANSPLANTATION TOLERANCE; TRANSPLANTATION, HOMOLOGOUS; USER-COMPUTER INTERFACE;

EID: 58849157789     PISSN: 00411337     EISSN: None     Source Type: Journal    
DOI: 10.1097/TP.0b013e318191404c     Document Type: Article

References (15)

1. Claas FH, van Rood JJ. Transplantation in hyperimmunized patients. Adv Nephrol Necker Hosp 1989; 18: 317.
2. Claas FH, van Rood JJ. The hyperimmunized patient: From sensitization toward transplantation. Transpl Int 1988; 1: 53.
3. Doxiadis II, De Meester J, Smits JM, et al. The impact of special programs for kidney transplantation of highly sensitized patients in Eurotransplant. Clin Transpl 1998: 115.
4. Bray RA, Nolen JD, Larsen C, et al. Transplanting the highly sensitized patient: The Emory algorithm. Am J Transplant 2006; 6: 2307.
5. Bielmann D, Honger G, Lutz D, et al. Pretransplant risk assessment in renal allograft recipients using virtual crossmatching. Am J Transplant 2007; 7: 626.
6. Zangwill S, Ellis T, Stendahl G, et al. Practical application of the virtual crossmatch. Pediatr Transplant 2007; 11: 650.
7. Zachary AA, Braun WE. Calculation ofapredictive value for transplantation. Transplantation 1985; 39: 316.
8. Pei R, Lee JH, Shih NJ, et al. Single human leukocyte antigen flow cytometry beads for accurate identification of human leukocyte antigen antibody specificities. Transplantation 2003; 75: 43.
9. Pei R, Wang G, Tarsitani C, et al. Simultaneous HLA Class I and Class II antibodies screening with flow cytometry. Hum Immunol 1998; 59: 313.
10. Racusen LC, Solez K, Colvin RB, et al. The Banff 97 working classification of renal allograft pathology. Kidney Int 1999; 55: 713.
11. Cecka JM. The OPTN/UNOS Renal Transplant Registry. Clin Transpl 2005:1.
12. Kerman R, Lappin J, Kahan B, et al. The crossmatch may still be the most clinically relevant histocompatibility test performed. Clin Transpl 2007:227.
13. Kerman RH. Understanding the sensitized patient. Heart Fail Clin 2007; 3: 1.
14. van den Berg-Loonen EM, Billen EV, Voorter CE, et al. Clinical relevance of pretransplant donor-directed antibodies detected by single antigen beads in highly sensitized renal transplant patients. Transplantation 2008; 85: 1086.
15. Gupta A, Iveson V, Varagunam M, et al. Pretransplant donor-specific antibodies in cytotoxic negative crossmatch kidney transplants: Are they relevant? Transplantation 2008; 85: 1200.